VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Dec. 28, 2005) - WEX Pharmaceuticals Inc. (“WEX” or “the Company”) (TSX:WXI) today announced the granting of stock options for 190,000 shares at a price of $1.50 with expiry dates up to December 27, 2010 to certain individuals pursuant to their respective service agreements with the Company. Dr. Jean Bourgouin, Executive Vice President/CMO, has been granted 100,000 stock options, Dr. Edge Wang, President/CEO, has been granted 50,000 stock options, and an employee and a consultant to the Company has been granted the remaining 40,000 stock options.